What Sain Medicaments does

Sain Medicaments Private Limited is an Indian generic pharmaceutical manufacturer headquartered in Hyderabad, Telangana, with a c-GMP compliant manufacturing facility of approximately 85,000 square feet at the IDA Uppal industrial area. The company was founded by Radheshyam Kanodia (around 1970–1973) and is currently led by Chairman and Managing Director Girish Gupta (40+ years in the pharma industry), with Director Sumit Agarwal overseeing quality, Director Manmeet Agarwal handling domestic sales and finance, and the founder as continuing visionary; ownership is private and concentrated among the founding family and management, with no external institutional investors disclosed.

The company manufactures tablets, capsules, syrups, injections, and topical dosage forms across 13 therapeutic categories (cardiac, psychotropics, hypoglycemics, multiple antibiotic classes such as beta-lactams/cephalosporins/fluoroquinolones/macrolides, anti-cold, analgesics/anti-inflammatory, antidiarrhoeal, anti-ulcerants/antacids, antivirals/antiretrovirals, nutraceuticals, ayurvedic, cosmetic/derma, and miscellaneous) producing an estimated 200+ branded SKUs (e.g., Adipin, Eszen, Dapasain, Cefixain, Teno-EM, Binavir). Core technical capabilities include in-house formulation development, a GLP-certified quality control lab, dedicated HVAC and water-loop systems, and compliance with WHO GMP, ISO 9001, c-GMP, PIC/s, and EU-GMP norms.

The revenue model is B2B direct sales of generic pharmaceutical products through dedicated domestic and export sales teams, with marketing and distribution partners in countries where it operates. The company serves both the Indian market and exports to 27+ countries across Latin America, Africa, Central Asia, South Asia, and Southeast Asia; pricing is not publicly disclosed and quotations are handled through the dedicated contact channels [email protected] (domestic) and [email protected] (export). In 2024, the company conducted a brand refresh under the tagline 'Reimagined. Reinvented. For the Greater Good.'

Name

Sain Medicaments

Legal name

Sain Medicaments Private Limited

Website

https://saingroup.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

101–250 employees

Short description

Sain Medicaments Private Limited is an Indian generic pharmaceutical manufacturer, headquartered in Hyderabad, that produces tablets, capsules, syrups, and injectables across 13 therapeutic categories for the Indian market and export to 27+ countries. The firm operates a WHO GMP/PIC/s/EU-GMP compliant facility and distributes through dedicated domestic and export sales channels.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

Keywords

• Generic pharmaceutical manufacturing
• Cardiovascular formulations
• Antiretroviral medications
• Pharmaceutical exports
• C-GMP manufacturing

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sain Medicaments generates revenue through the manufacture and sale of generic pharmaceutical products across multiple therapeutic categories including cardiac, psychotropics, hypoglycemic agents, antibiotics, anti-cold, analgesics, anti-diarrhoeal, anti-ulcerants, antiretrovirals, nutraceuticals, ayurvedic products, and cosmetics. The company serves both domestic Indian market and exports to 27+ countries across five continents.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Sain Medicaments manufactures and sells a broad portfolio of branded generic pharmaceutical formulations in tablet, capsule, syrup, suspension, injection, gel, cream, and topical dosage forms across 13 therapeutic categories including cardiac, psychotropics, hypoglycemic agents, antibiotics, anti-cold, analgesics, anti-diarrhoeal, anti-ulcerants, antiretrovirals, nutraceuticals, ayurvedic, and cosmetic/derma products. The company operates a c-GMP compliant facility in Hyderabad producing these formulations for distribution across India and 27+ export markets. Products are sold to healthcare providers, hospitals, pharmacies, and international pharmaceutical distributors through dedicated domestic and export sales teams.

Product overview

Sain Medicaments is a pharmaceutical company with over 50 years of experience manufacturing generic drugs across 13 therapeutic categories. The company's product portfolio is organized into distinct therapeutic segments including Cardiac products (antihypertensives, statins, anticoagulants like Rivasain, Asat, Olsat, Telsat, Corel), Psychotropics (antipsychotics, antidepressants, antiepileptics like Olzen, Eszen, Divazen, Flux), Hypoglycemic Agents (DPP-4 inhibitors, SGLT2 inhibitors, biguanides like Dapasain, Dior, Glipsy, Vill), Anti-Biotics (beta-lactams, cephalosporins, fluoroquinolones, macrolides organized in subcategories: Antimicrobials, Beta Lactum, Cephalosporins, Fluoroquinolones, General), Anti-Cold (cough expectorants, antihistamines like Ambroxain, Bilaxyl, Constan, L-Cet), Analgesics & Anti-Inflammatory (NSAIDs like Alto, Etosain, Nimeside, plus joint supplements Osteoflex), Anti-Diarrhoeal (antibiotics, laxatives like Laxain, PB-Lc), Anti-Ulcerants & Antacids (PPIs like Eszol, Panzol, Prozol, Raz plus antacids), Antivirals/Antiretrovirals (HIV medications like Hi-Zid, Teno-EM, Teno-EL, Enovir), Nutraceuticals & Health Supplements (vitamins, minerals, protein supplements like Basics, Calshel, Proglobin), Ayurvedic Products (herbal formulations like DN-Plus-Oil, Livosain-DS), Cosmetic & Derma (medicated soaps, skin care like Ketozen, Miracle), and Miscellaneous products (various specialty medications). The company operates as a diversified generic pharmaceutical manufacturer serving global markets across 27+ countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiac Pharmaceutical Product Line Branded generic cardiovascular formulations including calcium channel blockers (Amlodipine), beta blockers (Atenolol, Metoprolol), ARBs (Losartan, Olmesartan, Telmisartan), statins (Atorvastatin, Rosuvastatin), antiplatelet agents (Clopidogrel, Aspirin combinations), and direct oral anticoagulants (Rivaroxaban), in tablet and combination dosage forms, for hospitals, pharmacies, and healthcare providers.
• Psychotropics Pharmaceutical Product Line Branded generic psychotropic formulations including antipsychotics (Amisulpride, Aripiprazole, Olanzapine, Quetiapine), antidepressants (Escitalopram, Fluoxetine), benzodiazepines and anxiolytics (Clonazepam, Etizolam), antiepileptics (Divalproex, Levetiracetam, Brivaracetam), and nootropics (Citicoline, Piracetam), in tablet, dispersible, and chewable forms.
• Hypoglycemic Agents Product Line Branded generic antidiabetic formulations including SGLT2 inhibitors (Dapagliflozin), DPP-4 inhibitors (Sitagliptin, Vildagliptin, Teneligliptin), biguanides (Metformin), sulfonylureas (Glimepiride, Glipizide), alpha-glucosidase inhibitors (Voglibose), and various combination therapies, in immediate-release and sustained-release tablet forms.
• Antibiotics Product Line (Antimicrobials, Beta-Lactams, Cephalosporins, Fluoroquinolones, General) Branded generic antibiotic formulations including broad-spectrum antimicrobials (Chloramphenicol), beta-lactams (Amoxicillin, Amoxicillin-Clavulanate), macrolides (Azithromycin, Clarithromycin), cephalosporins across first, second, and third generation (Cefixime, Cefuroxime, Cephalexin, Cefpodoxime, Ceftriaxone, Piperacillin-Tazobactam), and fluoroquinolones (Ciprofloxacin, Levofloxacin, Ofloxacin, Moxifloxacin, Sparfloxacin), in tablet, dispersible, dry syrup, and injection forms.
• Anti-Cold Pharmaceutical Product Line Branded generic anti-cold and respiratory formulations including cough expectorants (Ambroxol combinations), bronchodilators (Salbutamol, Terbutaline, Levosalbutamol), antihistamines (Bilastine, Levocetirizine, Diphenhydramine, Chlorpheniramine), leukotriene antagonists (Montelukast), and combination cold medications with Paracetamol, in tablet, syrup, drop, and suspension forms.
• Analgesics and Anti-Inflammatory Product Line Branded generic analgesics and anti-inflammatory formulations including NSAIDs (Aceclofenac, Diclofenac, Etoricoxib, Nimesulide, Paracetamol), corticosteroids (Prednisolone), anti-inflammatory enzymes (Serratiopeptidase), muscle relaxants (Thiocolchicoside, Chlorzoxazone), joint health supplements (Glucosamine, Chondroitin, Diacerein), and topical gels, in immediate-release, sustained-release, delayed-release, and topical forms.
• Anti-Diarrhoeal Product Line Branded generic anti-diarrhoeal and gastrointestinal formulations including anthelmintics (Albendazole), antibiotic combinations (Ofloxacin-Metronidazole, Ofloxacin-Ornidazole, Ornidazole), osmotic laxatives (Lactulose), gut flora supplements (Pre and Probiotics), in tablet, suspension, and chewable forms.
• Anti-Ulcerants and Antacids Product Line Branded generic anti-ulcerant and antacid formulations including proton pump inhibitors (Omeprazole, Pantoprazole, Esomeprazole, Rabeprazole) and combinations with prokinetics (Domperidone, Levosulpiride, Itopride) and antiemetics (Ondansetron), antacids (Magaldrate, Aluminium-Magnesium hydroxide), gastroprotective agents (Sucralfate), in tablet, capsule, injection, and suspension forms.
• Antivirals and Antiretrovirals Product Line Branded generic antiretroviral and antiviral formulations including NRTIs (Zidovudine, Lamivudine, Stavudine, Tenofovir, Emtricitabine), NNRTIs (Efavirenz, Nevirapine), protease inhibitors (Lopinavir-Ritonavir, Ritonavir), hepatitis B antiviral (Entecavir), and triple-combination HIV therapies, in tablet form, supplied to HIV/AIDS treatment programs and international health agencies.
• Nutraceuticals and Health Supplements Product Line Branded nutraceutical and health supplement formulations including multivitamins and multiminerals (for kids, family, and premium segments), iron and calcium supplements, B-complex with probiotics, prenatal vitamins, protein supplements with DHA, antioxidants (CoQ10, Lycopene, Green Tea, Grape Seed), evening primrose oil, biotin, vitamin D3 sachets, and magnesium glycinate, in tablet, capsule, syrup, drops, sachet, and powder forms.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Alkem Laboratories: Indian generic manufacturer with a multi-therapeutic portfolio (anti-infectives, GI, cardiac, vitamins/dietary) and a domestic plus international branded-generic model. Closely comparable in product mix (especially anti-infectives, GI, and cardiac) and in selling into developing-market export geographies.
• TTK Healthcare: Diversified Indian healthcare company with a pharmaceutical division producing generic formulations across multiple therapeutic categories, plus consumer health products. Comparable to Sain on the multi-therapeutic generic model and the combination of pharma and consumer health (derma/cosmetics) offerings.
• Mankind Pharma: One of India's largest domestic-focused generic pharmaceutical manufacturers with a broad therapeutic portfolio (cardiac, anti-infectives, GI, vitamins) and strong primary-care prescription presence. Highly comparable to Sain in therapeutic breadth and Indian market orientation, though materially larger in scale and increasingly export-oriented.
• Unichem Laboratories: Indian generic manufacturer with therapeutic focus on cardiology, neurology, and gastroenterology, and an export business primarily to the US and select emerging markets. Comparable to Sain on the chronic-disease therapeutic mix and the generic manufacturing model.
• Torrent Pharmaceuticals: Indian generic manufacturer with a strong chronic-care portfolio (cardiac, anti-diabetic, CNS) and a meaningful international branded-generic franchise. Directly comparable to Sain on cardiac and anti-diabetic categories, and on the model of selling Indian-developed generics into emerging markets.
• Ajanta Pharma: Mid-sized Indian generic manufacturer with a therapeutic mix in cardiac, anti-diabetic, antibiotics, and anti-malarials, plus an emerging-market export franchise (Africa, Asia). Closely comparable to Sain on therapeutic breadth, scale, and geographic mix.
• IPCA Laboratories: Indian generic manufacturer with significant presence in anti-malarials, anti-infectives, and cardiovasculars, and a large export business to Africa, Asia, and Latin America. Comparable to Sain on the anti-infective and cardiac mix and on the strategy of selling affordable generics to developing markets.
• FDC Limited: Indian generic pharmaceutical company focused on anti-infectives, vitamins/nutritional, and ophthalmic/ENT products with a domestic and select international footprint. Comparable to Sain on the multi-therapeutic generic model and the emphasis on affordable mass-market formulations.

Emerging players

• Kopran Limited: Smaller-cap Indian generic manufacturer producing formulations and APIs across anti-infectives, cardiovasculars, and other categories, with both domestic and export presence. Comparable to Sain on therapeutic mix and Indian-generic-exporter model, though with more focus on API manufacturing.
• Lincoln Pharmaceuticals: Mid-sized Indian generic manufacturer with a focus on anti-infectives, gynecology, dermatology, and nutraceuticals, exporting to Africa, Asia, and Latin America. Closely comparable to Sain on the multi-therapeutic portfolio and the emerging-market export orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/LtdSain
• Facebookfacebook.com/Sainmedicaments
• LinkedInlinkedin.com/company/sain-medicaments-pvt-ltd

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sain Medicaments